Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Role of micro ribonucleic acids in progesterone resistance in endometriosis
EF 2018-19
Résumé
Endometriosis is a disorder in which endometrial tissue grows outside of the uterus; this tissue is known as ectopic endometrium. It is highly prevalent and causes pain and subfertility. It is known that ectopic endometrium is resistant to progesterone, one of the major female sex hormones, due to suppression of progesterone receptor (PR) expression. However, the mechanisms by which this suppression occurs have not been completely elucidated. Improved understanding of these mechanisms may lead to novel therapies based on the reversal of receptor suppression. MicroRNAs are short RNA molecules that regulate protein expression by binding to complementary mRNA molecules. mRNA molecules are read by cellular machinery to produce proteins, and the binding of microRNA prevents this reading. Previous research on progesterone resistance caused by microRNA-26a and microRNA-181a in breast cancer and endometrial cancer hint towards their possible involvement in endometriosis-associated progesterone resistance. I hypothesize that microRNA-26a and microRNA-181a are upregulated in ectopic endometrium and act to suppress PR expression. In this proposed research, endometrial samples will be collected from women without endometriosis and from the ectopic sites of women with endometriosis. microRNA-26a, microRNA-181a, and PR mRNA will be quantified in order to compare the differences in expression between healthy and ectopic endometrium. Cells taken from the ectopic samples will be cultured and treated with microRNA mimics and inhibitors. The protein content of the treated cells will be quantified to assess PR levels in relation to microRNA-26a or microRNA-181a concentrations.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406467
Name
Wang Jeremy
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of micro ribonucleic acids in progesterone resistance in endometriosis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ectopic; Endometriosis; Microrna; Mir-181a; Mir-26a; Progesterone Receptor; Progesterone Resistance
Abstract
Endometriosis is a disorder in which endometrial tissue grows outside of the uterus; this tissue is known as ectopic endometrium. It is highly prevalent and causes pain and subfertility. It is known that ectopic endometrium is resistant to progesterone, one of the major female sex hormones, due to suppression of progesterone receptor (PR) expression. However, the mechanisms by which this suppression occurs have not been completely elucidated. Improved understanding of these mechanisms may lead to novel therapies based on the reversal of receptor suppression. MicroRNAs are short RNA molecules that regulate protein expression by binding to complementary mRNA molecules. mRNA molecules are read by cellular machinery to produce proteins, and the binding of microRNA prevents this reading. Previous research on progesterone resistance caused by microRNA-26a and microRNA-181a in breast cancer and endometrial cancer hint towards their possible involvement in endometriosis-associated progesterone resistance. I hypothesize that microRNA-26a and microRNA-181a are upregulated in ectopic endometrium and act to suppress PR expression. In this proposed research, endometrial samples will be collected from women without endometriosis and from the ectopic sites of women with endometriosis. microRNA-26a, microRNA-181a, and PR mRNA will be quantified in order to compare the differences in expression between healthy and ectopic endometrium. Cells taken from the ectopic samples will be cultured and treated with microRNA mimics and inhibitors. The protein content of the treated cells will be quantified to assess PR levels in relation to microRNA-26a or microRNA-181a concentrations.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, Jeremy
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~